Influence of Different COVID-19 Pandemic Phases on STEMI: Experience From an Italian Hub Centre

Gabriele Tumminello1, Lucia Barbieri2, Filippo Toriello2

  • 1Cardiology Division, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.

Insights

During the COVID-19 pandemic, ST-elevation myocardial infarction (STEMI) patients with COVID-19 experienced significantly higher in-hospital mortality, primarily due to respiratory issues. Early diagnosis is crucial for managing these high-risk patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The Coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare systems globally, with observed changes in ST-elevation acute myocardial infarction (STEMI) incidence and outcomes.
  • Hospitals were reorganized, and this study analyzed STEMI patients across different pandemic phases to assess outcomes.

Discussion:

  • STEMI patients who contracted COVID-19 exhibited a substantially higher in-hospital mortality rate (47.1%) compared to non-COVID-19 patients (8.6%).
  • The increased mortality in COVID-19 positive STEMI patients was predominantly linked to respiratory complications, not cardiac events.
  • The incidence of STEMI remained consistent across different pandemic phases, irrespective of COVID-19 prevalence in the general population.

Key Insights:

  • COVID-19 infection is the strongest independent predictor of in-hospital mortality among STEMI patients.
  • Respiratory complications are the main drivers of mortality in STEMI patients with COVID-19.
  • The number of STEMI hospitalizations did not significantly change during the pandemic phases.

Outlook:

  • Emphasizes the critical need for prompt and accurate COVID-19 diagnosis in STEMI patients.
  • Highlights the necessity of tailored management strategies for high-risk STEMI patients co-infected with COVID-19.
  • Suggests continued research into the complex interplay between cardiovascular events and viral infections.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
180
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
54
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
62
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
76
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
95
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74